First Time Loading...

PharmaSGP Holding SE
XETRA:PSG

Watchlist Manager
PharmaSGP Holding SE Logo
PharmaSGP Holding SE
XETRA:PSG
Watchlist
Price: 22.6 EUR -1.74%
Updated: May 6, 2024

PharmaSGP Holding SE
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

PharmaSGP Holding SE
Cash from Financing Activities Peer Comparison

Comparables:
ATAI
BAYN
MRK
93M1
DMP

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
PharmaSGP Holding SE
XETRA:PSG
Cash from Financing Activities
-€12.1m
CAGR 3-Years
-28%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ATAI Life Sciences NV
NASDAQ:ATAI
Cash from Financing Activities
-$8.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bayer AG
XETRA:BAYN
Cash from Financing Activities
-€679m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
12%
Merck KGaA
XETRA:MRK
Cash from Financing Activities
-€1.7B
CAGR 3-Years
-4%
CAGR 5-Years
9%
CAGR 10-Years
-5%
MPH Health Care AG
XETRA:93M1
Cash from Financing Activities
-€3.2m
CAGR 3-Years
30%
CAGR 5-Years
11%
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Cash from Financing Activities
€204.5m
CAGR 3-Years
N/A
CAGR 5-Years
4%
CAGR 10-Years
N/A

See Also

What is PharmaSGP Holding SE's Cash from Financing Activities?
Cash from Financing Activities
-12.1m EUR

Based on the financial report for Dec 31, 2022, PharmaSGP Holding SE's Cash from Financing Activities amounts to -12.1m EUR.

What is PharmaSGP Holding SE's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-28%

The average annual Cash from Financing Activities growth rates for PharmaSGP Holding SE have been -28% over the past three years .